Prior research has shown that maternal-fetal Rhesus (Rh) and ABO blood incompatibility increase the risk for schizophrenia. In the present study, the relationship between blood incompatibility and volumes of brain structures previously implicated in schizophrenia was assessed in schizophrenia cases and controls from a large birth cohort. Rh/ABO incompatible cases had significantly reduced cortical gray matter volume compared to compatible cases, a finding which appears to be driven by significant volume reductions in the dorsolateral prefrontal cortex and inferior frontal cortex. Larger hippocampal and putamen volumes were also observed in exposed controls compared to unexposed controls. Although the sample size is small and replications are required, these data suggest that maternal-fetal blood incompatibility may increase the risk for altered brain morphology in both schizophrenia and in controls. The findings also suggest that the larger hippocampal volume in exposed controls may indicate a mechanism of adaptive resilience which diminishes the risk that controls will develop schizophrenia.
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Prior research has shown that maternal-fetal blood incompatibility heightens the risk for schizophrenia later in life. In the pioneering study, Hollister et al. (1996) found that second and later born offspring of Rhesus (Rh) incompatible pregnancies had an increased occurrence of schizophrenia (Hollister et al., 1996) . More recently, from the birth cohort of the present study, Insel et al. (2005) found that both Rh and ABO incompatibility increased the risk of schizophrenia in second and later born offspring, with greater risk for males than females (Insel et al., 2005) . These findings have been observed by others, including in three meta-analyses (Cannon et al., 2002; Geddes and Lawrie, 1995; Palmer, 2010; Palmer et al., 2008) .
Rh incompatibility occurs when an Rh negative mother becomes pregnant with an Rh positive fetus. Maternal alloantibodies in response to Rh D antigen cross the placenta, causing hemolytic disease, leading to hyperbilirubinemia in the fetus and newborn and subsequent brain damage (Hollister et al., 1996) . At the extreme, kernicterus results. Infants who survive kernicterus typically manifest signs of overt brain dysfunction including mental retardation or other cognitive impairments, motor dysfunction and hearing deficits (Creasy et al., 2004; Watchko and Oski, 1992) . Hollister et al. (1996) proposed that Rh incompatibility may be related to schizophrenia based in part on the common central nervous system (CNS) sequelae: neuromotor and neurocognitive dysfunction. ABO incompatibility also causes hemolytic disease of the newborn and has similar potential effects on brain development. As a result of successful prophylactic treatments for Rh incompatibility, mainly in the developed world, ABO incompatibility may be a more significant cause of hemolytic disease among offspring in these countries (Murray and Roberts, 2007) .
First episode and prodromal studies of patients with schizophrenia have documented differences in brain structure for those who later develop schizophrenia or psychosis, suggesting that these neuromorphologic influences are present before onset of the disorder (Pantelis et al., 2003; Seidman et al., 2010) . Documenting associations between known risk factors for schizophrenia, such as Rh incompatibility, could help identify risk factors for structural brain changes in schizophrenia, and validate their potential role in the etiology of this disorder (Brown, 2011 
